{
    "clinical_study": {
        "@rank": "149557", 
        "arm_group": {
            "arm_group_label": "Treatment by the Liberty Stent", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the safety and performance of the Penumbra Liberty\n      Stent System as adjunctive treatment to embolic coils for wide-neck, saccular, intracranial\n      aneurysms."
        }, 
        "brief_title": "Safety and Performance of the Penumbra Liberty Stent in the Treatment of Wide-Neck, Saccular, Intracranial Aneurysms", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Wide Neck Intracranial Aneurysms", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Intracranial Aneurysm"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient from 18 to 85 years old\n\n          -  A symptomatic unruptured saccular intracranial aneurysm with  a neck \u22654mm (or a dome\n             to neck ratio <2) and a parent vessel diameter between 2.5 to 5.0 mm (inclusive) in\n             both the anterior and posterior circulation of the brain, that is amenable to\n             stent-assisted coiling. \"Symptomatic\" is defined as any neurological symptoms\n             attributed to the target aneurysm.\n\n          -  Life expectancy >6 months\n\n          -  Signed Informed Consent\n\n        Exclusion Criteria:\n\n          -  Aneurysm with branches from the aneurysm base\n\n          -  Rapidly growing aneurysm\n\n          -  Daughter aneurysm\n\n          -  Aneurysm with partial or complex calcifications\n\n          -  Females who are nursing, pregnant or intend to become pregnant during the study.\n             Females of child-bearing potential must have a urinary pregnancy test within 7 days\n             of enrollment and use an approved highly efficient contraceptive method during the\n             study\n\n          -  Multiple untreated cerebral aneurysms at study entry\n\n          -  Recent history of stroke, TIA, subarachnoid hemorrhage, intracranial hemorrhage, or\n             major surgery within one month of enrollment\n\n          -  Previous brain surgery or irradiation of the target treatment territory that would,\n             in the opinion of the investigator, interfere with the treatment of the target\n             aneurysm\n\n          -  Admission platelet <150,000 or any known hemorrhagic diathesis, coagulation\n             deficiency, or on oral anticoagulant therapy\n\n          -  Underlying unstable Coronary Artery Disease, cardiac insufficiency or Myocardial\n             Infarction\n\n          -  Contraindication to angiography such as elevated creatinine or known allergy to\n             angiographic contrast\n\n          -  Contraindication to CT and/or MRI scans\n\n          -  Known allergy to the metal component of the Penumbra Liberty Stent System\n\n          -  Evidence of active infection (WBC >10x109/L)\n\n          -  Any medical conditions that will not allow the necessary follow-up for this study\n             (e.g., pre-existing neurological or psychiatric diseases)\n\n          -  Current substance-abuse/illicit drug use\n\n          -  Angiographic evidence of an arterial stenosis proximal to the target lesion that\n             could prevent device deployment\n\n          -  Contraindications to study medications (heparin, aspirin, clopidogrel, and\n             radiographic contrasts)\n\n          -  Patients unable to sign Informed Consent due to the emergency conditions of the\n             intervention"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01753388", 
            "org_study_id": "CLP 4928", 
            "secondary_id": "CLP 4928"
        }, 
        "intervention": {
            "arm_group_label": "Treatment by the Liberty Stent", 
            "intervention_name": "Liberty Stent", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 19, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Prof. Dr. med. Bernd Eckert"
                }, 
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany"
                    }, 
                    "name": "Asklepios Klinik Altona"
                }, 
                "investigator": {
                    "last_name": "Prof. Dr. med. Bernd Eckert", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Prof. Dr. med. Wolfgang Reith"
                }, 
                "facility": {
                    "address": {
                        "city": "Homburg/Saar", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum des Saarlandes"
                }, 
                "investigator": {
                    "last_name": "Prof. Dr. med. Wolfgang Reith", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Prof. Dr. med. Martin Skalej"
                }, 
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum Magdeburg A. \u00f6. R."
                }, 
                "investigator": {
                    "last_name": "Prof. Dr. med. Martin Skalej", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "PD Dr. med. Werner Weber"
                }, 
                "facility": {
                    "address": {
                        "city": "Recklinghausen", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum Vest GmbH, Knappschaftskrankenhaus Recklinghausen"
                }, 
                "investigator": {
                    "last_name": "PD Dr. med Werner Weber", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "Safety and Performance of the Penumbra Liberty Stent in the Treatment of Wide-Neck, Saccular, Intracranial Aneurysms", 
        "overall_contact": {
            "email": "osellam@penumbrainc.com", 
            "last_name": "Olivier Salem, PhD", 
            "phone": "33 6 82 33 05 06"
        }, 
        "overall_contact_backup": {
            "email": "siupo.sit@penumbrainc.com", 
            "last_name": "Siu Po Sit, PhD", 
            "phone": "510 748 3200", 
            "phone_ext": "221"
        }, 
        "overall_official": {
            "affiliation": "Klinikum Vest GmbH, Knappschaftskrankenhaus Recklinghausen", 
            "last_name": "Werner Weber, PD Dr. med", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany:Bundesinstitut fuer Arzneimittel und Medizinprodukte (BfArM)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Aneurysmal occlusion of the treated target lesion on 6-month angiography as defined by the method of Roy et al. (Stroke 2001;32:1998-2004).", 
                "safety_issue": "No", 
                "time_frame": "6 months post-procedure"
            }, 
            {
                "measure": "Procedural device-related serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "During the procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01753388"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Device patency and migration", 
                "safety_issue": "Yes", 
                "time_frame": "At 6 months post-procedure"
            }, 
            {
                "measure": "Intracranial hemorrhage", 
                "safety_issue": "Yes", 
                "time_frame": "At 6 months post-procedure"
            }, 
            {
                "measure": "Functional outcome as defined by the modified Rankin Scale (mRS)", 
                "safety_issue": "Yes", 
                "time_frame": "At 6 months post-procedure"
            }, 
            {
                "measure": "All cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "At 6 months post-procedure"
            }, 
            {
                "measure": "Retreatment", 
                "safety_issue": "No", 
                "time_frame": "At 6 months"
            }
        ], 
        "source": "Penumbra Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Penumbra Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}